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Accepted 21 June 2013AbstractObjective: To present prenatal diagnosis of partial monosomy 5p (5p14.1/ pter) and partial monosomy 14q (14q32.31/ qter).
Materials and Methods: A 33-year-old woman underwent amniocentesis at 20 weeks of gestation because of abnormal fetal ultrasound.
Amniocentesis revealed a dicentric chromosome of dic(5;14). Level II ultrasound at 23 weeks of gestation revealed a fetus with intrauterine
growth restriction, microcephaly, nuchal edema, a single umbilical artery, and fetal biometry equivalent to 19 weeks. At 23 weeks of gestation,
she requested repeated amniocentesis. Whole-genome array comparative genomic hybridization on uncultured amniocytes was performed.
Quantitative fluorescent polymerase chain reaction analysis was performed on uncultured cord blood and parental blood. A fetus was delivered
with microcephaly, low-set ears, hypertelorism, depressed nasal bridge, increased nuchal fold, and a single umbilical artery.
Results: The fetal karyotype was 45,XX,dic(5;14)(p14.1;q32.31)dn. Whole-genome array comparative genomic hybridization analysis on un-
cultured amniocytes detected arr 5p15.33p14.1 (36,238-28,798,509)1 and arr 14q32.31q32.33 (101,508,967-107,349,540)1. Quantitative
fluorescent polymerase chain reaction assays showed that the aberrant dic(5;14) was from paternal origin.
Conclusion: Concomitant occurrence of monosomy for distal 5p and distal 14q my present nuchal edema, microcephaly, IUGR, and single
umbilical artery on prenatal ultrasound.
Copyright  2013, Taiwan Association of Obstetrics & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
Keywords: 5p deletion; 14q deletion; microcephaly; nuchal edema; single umbilical artery
Introduction* Corresponding author. Department of Obstetrics and Gynecology, Mackay
Memorial Hospital, 92, Section 2, Chung-Shan North Road, Taipei, Taiwan.
E-mail address: cpc_mmh@yahoo.com (C.-P. Chen).
1028-4559/$ - see front matter Copyright  2013, Taiwan Association of Obstetri
http://dx.doi.org/10.1016/j.tjog.2013.06.005Partial monosomy for distal 5p can present the cri-du-chat
syndrome (OMIM 123450), which is characterized by a high-
pitched, monotonous cry, growth delay, psychomotor andcs & Gynecology. Published by Elsevier Taiwan LLC. All rights reserved.
402 C.-P. Chen et al. / Taiwanese Journal of Obstetrics & Gynecology 52 (2013) 401e406mental retardation, microcephaly, broad nasal bridge, epi-
canthic folds, micrognathia, and abnormal dermatographics,
and less frequent malformations of cardiac, neurological, and
renal abnormalities, preauricular tags, syndactyly, hypospa-
dias, and cryptorchidism [1,2].
Partial monosomy for distal 14q can present as the terminal
14q deletion syndrome, which is characterized by intellectual
disability, developmental delay, microcephaly, growth retar-
dation, muscular hypotonia, congenital heart defects, genito-
urinary malformations, ocular coloboma, and facial
dysmorphisms [3e9].
Concomitant occurrence of monosomy for distal 5p and
distal 14q has not previously been described. Here, we present
our experience of prenatal diagnosis and molecular cytogenetic
characterization of partial monosomy 5p (5p14.1/ pter) and
partial monosomy 14q (14q32.31/ qter) in a fetus associated
with de novo dic(5;14)(p14.1;q32.31), nuchal edema, micro-
cephaly, intrauterine growth restriction (IUGR), and a single
umbilical artery.Materials and methodsArray comparative genomic hybridization (aCGH)Whole-genome aCGH on uncultured amniocytes derived
from 10 mL of amniotic fluid was performed using Nim-
bleGen ISCA Plus Cytogenetic Array (Roche NimbleGen,
Madison, WI, USA). The NimbleGen ISCA Plus Cytogenetic
Array has 630,000 probes and a median resolution ofFig. 1. Karyotype of 45,XX,15e20 kb across the entire genome according to the manu-
facturer’s instructions.Conventional cytogenetic analysisRoutine cytogenetic analysis by G-banding techniques at
the 550 bands of resolution was performed. About 16 mL of
amniotic fluid was collected, and the sample was subjected to
in situ amniocyte culture according to the standard cytogenetic
protocol. Parental blood was collected, and the samples were
subjected to lymphocyte culture according to the standard
blood cytogenetic protocol.Quantitative fluorescent polymerase chain reaction (QF-
PCR)QF-PCR analysis was performed on uncultured cord blood
and parental blood. Polymorphic DNA markers such as
D5S1492 (5p15.33; 3,712,691-3,712,806), D5S814 (5p14.1;
25,885,414-25,885,587), and D5S2489 (5p13.1; 39,711,921-
39,712,065) were used to determine the parental origin of the
deletion.Clinical descriptionA 33-year-old, primigravid woman underwent amniocentesis
at 20 weeks of gestation because of a single umbilical artery,
nuchal edema, microcephaly, and IUGR in the fetus. Her
husband was 35 years of age. She and her husband weredic(5;14)(p14.1;q32.31).
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congenital malformations. Amniocentesis revealed a dicentric
chromosome of dic(5;14) (Fig. 1). Level II ultrasound at 23weeks
of gestation revealed a fetus with IUGR, microcephaly, nuchal
edema, a single umbilical artery, and fetal biometry equivalent to
19weeks.The fetal biparietal diameterwasmeasured to be44mm
(2 centile for 23 weeks) and head circumference of 170 mm (8.5
centile for 23 weeks). The amniotic fluid level was normal. In-
ternal organs were unremarkable. At 23 weeks of gestation, she
requested repeated amniocentesis at another hospital. Whole-
genome aCGH analysis on uncultured amniocytes revealed a
28.76-Mb deletion at 5p15.33-p14.1 and a 5.84-Mb deletion at
14q32.31-q32.33 (Fig. 2). Conventional cytogenetic analysis
revealed a dic(5;14) chromosome with deletions of distal 5p andFig. 2. Array comparative genomic hybridization on uncultured amniocytes sh
5p15.33q14.1 (36,238-28,798,509)1 (NCBI build 37) and (B) a 5.84-Mb deletion
107,349,540)1 (NCBI build 37).terminal 14q (Fig. 1). The parents elected to terminate the preg-
nancy, and a 630-g malformed female fetus was delivered with
microcephaly, low-set ears, hypertelorism, depressed nasal
bridge, increased nuchal fold, and a single umbilical artery (Figs.
3 and 4). The joints and digits were normal. Postnatal cytogenetic
analysis of cord blood confirmed the prenatal diagnosis. QF-PCR
analysis of cord blood andparental blood showed that the aberrant
dic(5;14) chromosome was of paternal origin (Fig. 5).
Results
The fetal karyotype was 45,XX,dic(5;14)(p14.1;q32.31)dn
(Fig. 1). The father’s karyotype was 46,XY and the mother’s
karyotype was 46,XX. Whole-genome aCGH analysis onows (A) a 28.76-Mb deletion at chromosome bands 5p15.33-p14.1, or arr
at chromosome bands 14q32.31-q32.33, or arr 14q32.31q32.33 (101,508,967-
Fig. 3. Craniofacial appearance of the fetus at birth.
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28,798,509)1 and arr 14q32.31q32.33 (101,508,967-
107,349,540)1 (NCBI build 37) (Fig. 2). The 28.76-Mb
deletion at 5p15.33-p14.1 encompassed 172 genes including
51 OMIM genes of SDHA, PDCD6, AHRR, EXOC3, SLC9A3,
TPPP, TRIP13, NKD2, SLC12A7, SLC6A19, SLC6A18, TERT,
CLPTM1L, SLC6A3, LPCAT1, MRPL36, NDUFS6, IRX4,
IRX2, C5orf38, IRX1, ADAMTS16, MED10, NSUN2, SRD5A1,
PAPD7, ADCY2, MTRR, SEMA5A, TAS2R1, CCT5, CMBL,
MARCH6, ROPN1L, DAP, CTNND2, DNAH5, TRIO, ANKH,
FBXL7, MARCH11, ZNF622, FAM134B, MYO10, BASP1,
CDH18, CDH12, PMCHL1, PRDM9, CDH10, and CDH9.
The 5.84-Mb deletion at 14q32.31-q32.33 encompassed 304
genes including 55 OMIM genes of MIR487B, MIR134,
MIR409, MIR369, MIR410, DIO3OS, DIO3, PPP2R5C,
DYNC1H1, HSP90AA1, MOK, CINP, TECPR2, RCOR1,
TRAF3, AMN, CDC42BPB, TNFAIP2, EIF5, MARK3, CKB,
BAG5, KLC1, XRCC3, ZFYVE21, PPP1R13B, C14orf2,
MIR203, KIF26A, INF2, ADSSL1, SIVA1, AKT1, ZBTB42,
AHNAK2, CDCA4, GPR132, JAG2, NUDT14, BRF1, PACS2,Fig. 4. Umbilical cord with a single umbilical artery.MTA1, CRIP2, CRIP1, IGHA2, IGHE, IGHG4, IGHG2,
IGHA1, IGHG1, IGHG3, IGHD, IGHM, IGHD3-3, and
IGHV3-23. QF-PCR assays showed only the maternal allele in
the fetus on the informative markers of D5S1492 (5p15.33)
and D5S814 (5p14.1), indicating that the aberrant dic(5;14)
was of paternal origin (Fig. 5).Discussion
Prenatal detection of a paternal-origin deletion of distal 14q
should alert one to maternal uniparental disomy (UPD) 14
[10]. Microdeletions affecting the 14q32.2 imprinting region
of paternal origin have been associated with maternal UPD14-
like phenotype [10e12]. Maternal UPD14 is characterized by
short stature, growth retardation, muscular hypotonia, joint
laxity, truncal obesity, small hands, hyperextensible joints,Fig. 5. Quantitative fluorescent polymerase chain reaction assays show only
the maternal allele in the fetus on the informative markers of D5S1492
(5p15.33) and D5S814 (5p14.1), indicating that the aberrant dic(5;14) chro-
mosome is from a paternal origin.
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case had a paternal-origin deletion of distal 14q. However, the
present case manifested IUGR but no abnormalities of the
joints and digits. The 14q deletion region (14q32.31/ qter)
in the present case was distal to the chromosome 14 genomic
imprinting region at 14q32.2, which harbors the paternally
expressed genes of DLK1 and RTL1, maternally expressed
gene of MEG3, RTL1as, and MEG8, and the differentially
methylated regions (DMRs) of intergenic DMR and MEG3-
DMR (Fig. 2B).
The present case had a 5.84-Mb deletion at 14q32.31-
q32.33, encompassing the genes of DYNC1H1, TECPR2,
XRCC3, INF2, MTA1, and CRIP2. DYNC1H1 (OMIM
600112) encodes cytoplasmic 1, heavy chain 1 dynein, and
cytoplasmic dynein plays a role in mammalian mitotic spindle
formation and retrograde axonal transport in neurons [15,16].
Heterozygous mutations in the DYNC1H1 are associated with
autosomal dominant axonal CharcoteMarieeTooth disease
type 2O (CMT2O; OMIM 614228) [17]; autosomal dominant
mental retardation 13 (MRD13; OMIM 614563) with neuronal
migration defects [16]; and autosomal dominant lower ex-
tremity spinal muscular atrophy (SMALED; OMIM 158600)
[18]. TECPR2 (OMIM 615000) encodes tectonin b-propeller
repeat-containing protein 2, which is a positive regulator of
autophagy [19]. Homozygous mutations in TECPR2 are
associated with impaired autophagy and autosomal recessive
spastic paraplegia 49 (SPG49; OMIM 615031) [19]. Auto-
phagy dysfunction may play a role in progressive neurode-
generative diseases [19]. XRCC3 (OMIM 600675) encodes X-
ray repair cross-complementing protein 3, which interacts with
RAD51, promotes chromosome stability, and protects against
DNA crosslinks and other damage [20]. XRCC3 poly-
morphisms are associated with susceptibility to cutaneous
malignant melanoma 6 (OMIM 613972) [21] and breast can-
cer (OMIM 114480) [22] INF2 (OMIM 610982) encodes
inverted formin 2, which severs actin filaments and accelerates
polymerization and depolymerization, and involves an actin-
dependent step in mitochondrial fission [23,24]. Heterozy-
gous mutations in the INF2 are associated with autosomal
dominant focal segmental glomerulosclerosis 5 (OMIM
613237) [25] and autosomal dominant intermediate Char-
coteMarieeTooth disease E with focal segmental glomer-
ulosclerosis [26]. Engels et al [7] have suggested that MTA1
(OMIM 603526), CRIP2 (OMIM 601183), and TMEM1 are
the most promising candidate genes for intellectual disability
in the terminal deletion 14q syndrome.
The present case had a 28.76-Mb deletion at 5p15.33-
p14.1, encompassing the genes of TPPP, TERT, SEMA5A,
and CTNND2. TPPP (OMIM 608773) encodes tubulin
polymerization-promoting protein that is expressed mainly in
myelinating oligodendrocytes of the central nervous system
and is critical for oligodendrocyte differentiation [27e29].
TERT (OMIM 187270) encodes telomerase reverse transcrip-
tase, which is the rate-limiting component for telomerase ac-
tivity that is essential for telomere-length maintenance and
sustained cell proliferation. Mutations in TERT are associated
with susceptibility to telomere-related pulmonary fibrosis(OMIM 614742) [30], susceptibility to acute myeloid leuke-
mia (OMIM 601626) [31], susceptibility to coronary artery
disease [32], susceptibility to aplastic anemia (OMIM 614742)
[33], autosomal dominant dyskeratosis congenita 2 (OMIM
613989) [34], and autosomal recessive dyskeratosis congenita
4 (OMIM 613989) [35]. SEMA5A (OMIM 609297) encodes
human semaphorin F that is involved in axonal guidance
during neural development [36]. Simmons et al [37] suggested
that SEMA5A may be responsible for some of the features of
cri-du-chat syndrome and covers at least 10% of the critical
region of cri-du-chat syndrome. CTNND2 (OMIM 604275)
encodes human d-catenin, which is an adherens junction
protein involved in cell motility and expressed early in
neuronal development [38]. Medina et al [38] suggested that
CTNND2 is responsible for mental retardation in cri-du-chat
syndrome.
The pregnant woman in our study belongs to the low-risk
group of aneuploidy based on maternal age. She underwent
amniocentesis because of abnormal ultrasound findings of
fetal nuchal edema, microcephaly, IUGR, and a single um-
bilical artery. The cri-du-chat syndrome is detected prenatally
because of advanced maternal age, familial cri-du-chat syn-
drome, parental balanced translocation involving 5p, abnormal
maternal serum screening, and fetal structural abnormalities
on prenatal ultrasound [1]. The reported ultrasound abnor-
malities associated with distal 5p deletion include nuchal skin
edema, single umbilical artery, hydronephrosis, microcephaly,
choroid plexus cysts, ventriculomegaly, cerebellar hypoplasia,
and congenital heart defects [1,39e44]. Prenatal diagnosis of
nuchal edema, single umbilical artery, IUGR, and/or micro-
cephaly should alert one to rare chromosome aberrations other
than common aneuploidy of trisomies 21, 18, and 13 [45e47].
In summary, we present prenatal diagnosis and molecular
cytogenetic characterization of a de novo distal 5p deletion
and distal 14q deletion in a fetus with ultrasound abnormal-
ities. We discuss the genotypeephenotype correlation in this
case and the consequence of the gene dysfunction in the
involved genes of DYNC1H1, TECPR2, XRCC3, INF2, MTA1,
CRIP2, TPPP, TERT, SEMA5A, and CTNND2.
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